A Canadian cannabis company is set to study minor cannabinoids for the treatment of epilepsy as part of a National Institute of Health (NIH) programme. Cannabis...
Andrew Megahy, lead science officer at Always Pure Organics, explains more about CBDA and CBGA.
The cannabinoid acids bind to the SARS-CoV-2 protein blocking a step in the process of infection.
The study is the next stage in research examining the efficacy of different cannabinoids for treatment of Dravet Syndrome
As other cannabinoids such as CBG, CBGa and CBC are being added to CBD products, we ask what health benefits they could have
Dr Lyndsey Anderson said there is more to explore when it comes to creating more treatment options for Dravet syndrome.